OAM
ELV icon

Oxford Asset Management’s Elevance Health ELV Stock Holding History

Oxford Asset Management’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-4,138
Closed -$1.34M – 566
2025
Q3 		$1.34M Buy
+4,138
New +$1.29M 0.44% 46
2025
Q1 		– Sell
-1,776
Closed -$655K – 539
2024
Q4 		$655K Buy
1,776
+238
+15% +$99.6K 0.29% 101
2024
Q3 		$800K Buy
+1,538
New +$822K 0.67% 25
2019
Q2 		– Sell
-1,949
Closed -$559K – 1778
2019
Q1 		$559K Buy
+1,949
New +$564K 0.01% 1168
2018
Q1 		– Sell
-8,930
Closed -$2.03M – 1687
2017
Q4 		$2.03M Sell
8,930
-13,596
-60% -$2.9M 0.04% 567
2017
Q3 		$4.27M Buy
22,526
+18,456
+453% +$3.51M 0.08% 271
2017
Q2 		$766K Buy
+4,070
New +$731K 0.02% 975

Other funds holding ELV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Oxford Asset Management's ELV Position: Q4 2025 in Review

Oxford Asset Management sold out of Elevance Health (ELV) in Q4 2025, closing a stake of 4,138 shares — an estimated $1.34M sold.

Oxford Asset Management first reported a position in ELV in Q2 2017 and held it in 7 quarters. The position peaked at $4.27M in Q3 2017. 1,553 funds tracked by Wall St. Rank hold ELV as of Q4 2025.

  • Oxford Asset Management reported no remaining Elevance Health position as of Q4 2025 after selling out during the quarter.
  • Oxford Asset Management sold 4,138 Elevance Health shares in Q4 2025, an estimated $1.34M.
  • Oxford Asset Management first reported a position in Elevance Health in Q2 2017 and held it in 7 quarters.
  • Oxford Asset Management's Elevance Health position peaked at $4.27M in Q3 2017.
  • 1,553 funds tracked by Wall St. Rank held Elevance Health as of Q4 2025.

Based on Oxford Asset Management's 13F filing for Q4 2025, filed 17 Feb 2026.